Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg
PHASE1
The purpose of this study was to determine whether the administration of BI...
Status
Completed
Location
Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA